This report focuses on the global Thyroid Gland Disorder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thyroid Gland Disorder Treatment development in United States, Europe and China. Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave?s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders. The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period. One of the primary drivers for the market growth is the escalating?patient population with iodine deficiency. Iodine deficiency is predominant around the globe when compared with the large consumers of iodine and is particularly seen in pregnant women and young children. Iodine is present in the body in minute amounts, mainly in the thyroid gland and has a significant role to play in the thyroid synthesis.? It has been observed that over two billion individuals have insufficient iodine intake, among which South Asia and sub-Saharan Africa are majorly affected. The introduction of various remedies for the treatment of this deficiency will boost market growth in the coming years. In 2017, the global Thyroid Gland Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Abbott bioM?rieux Danaher DiaSorin Siemens Healthineers ... Market segment by Type, the product can be split into Hyperthyroidism Hypothyroidism Others Market segment by Application, split into Men Women Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Thyroid Gland Disorder Treatment status, future forecast, growth opportunity, key market and key players. To present the Thyroid Gland Disorder Treatment development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Thyroid Gland Disorder Treatment are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Thyroid Gland Disorder Treatment Market Size Growth Rate by Type (2013-2025) 1.4.2 Hyperthyroidism 1.4.3 Hypothyroidism 1.4.4 Others 1.5 Market by Application 1.5.1 Global Thyroid Gland Diso